Carl N. Kraus
Chief Medical Officer · Aquestive Therapeutics, Inc.
- 2025
- Oct 15, 2025
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Carl N. Kraus files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Barber - $1.22M in AQST purchases and sales in the last 12 months
- A. Ernest Toth Jr. - $243K in AQST purchases and sales in the last 12 months
- Cassie Jung - $191K in AQST purchases and sales in the last 12 months
- Lori J. Braender - $167K in AQST purchases and sales in the last 12 months
- Julie Krop - $125K in AQST purchases and sales in the last 12 months
- Peter E. Boyd - $124K in AQST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Carl N. Kraus?
Carl N. Kraus is a corporate insider, tracked as Chief Medical Officer of Aquestive Therapeutics, Inc. (AQST). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Carl N. Kraus last file a Form 4?
The most recent primary Form 4 on record is dated 15 October 2025, one of 2 filings going back to 2025.
Has Carl N. Kraus been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($142K) across all tracked filings.
